Crescent Biopharma to Present at September Investor Conferences

Core Insights - Crescent Biopharma, Inc. is focused on advancing innovative therapies for cancer patients, with a pipeline that includes a PD-1 x VEGF bispecific antibody and novel antibody-drug conjugates [2] Company Overview - Crescent Biopharma aims to become a leading oncology company by developing transformative therapies for solid tumors, utilizing multiple modalities and established targets [2] Upcoming Events - The company will present at the Cantor Global Healthcare Conference on September 4, 2025, and at the Morgan Stanley Annual Global Healthcare Conference on September 8, 2025 [3]